Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for IQV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 2.08B
March 31, 2026 2.103B
December 31, 2025 2.141B
September 30, 2025 1.972B
June 30, 2025 2.188B
March 31, 2025 1.876B
December 31, 2024 1.843B
September 30, 2024 1.712B
June 30, 2024 1.678B
March 31, 2024 1.575B
December 31, 2023 1.496B
September 30, 2023 1.332B
June 30, 2023 1.492B
March 31, 2023 1.598B
December 31, 2022 1.309B
September 30, 2022 1.361B
June 30, 2022 1.518B
March 31, 2022 1.493B
December 31, 2021 1.477B
September 30, 2021 1.574B
June 30, 2021 1.911B
March 31, 2021 2.402B
December 31, 2020 1.902B
September 30, 2020 1.543B
June 30, 2020 1.182B
Date Value
March 31, 2020 990.00M
December 31, 2019 899.00M
September 30, 2019 920.00M
June 30, 2019 994.00M
March 31, 2019 991.00M
December 31, 2018 938.00M
September 30, 2018 879.00M
June 30, 2018 928.00M
March 31, 2018 1.007B
December 31, 2017 1.005B
September 30, 2017 1.147B
June 30, 2017 945.00M
March 31, 2017 905.00M
December 31, 2016 1.238B
September 30, 2016 1.252B
June 30, 2016 996.96M
March 31, 2016 1.093B
December 31, 2015 979.63M
September 30, 2015 1.084B
June 30, 2015 806.76M
March 31, 2015 781.81M
December 31, 2014 870.24M
September 30, 2014 648.55M
June 30, 2014 639.76M
March 31, 2014 744.75M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. 502.69M
Charles River Laboratories International, Inc. 216.45M
Moderna, Inc. 5.138B
Fortrea Holdings, Inc. 168.60M
OmniAb, Inc. 52.00M